62 related articles for article (PubMed ID: 21737621)
1. Predicting response to benzamide riboside chemotherapy in hepatocellular carcinoma using apparent diffusion coefficient of water.
Babsky AM; Ju S; George B; Bennett S; Huang M; Jayaram HN; McLennan G; Bansal N
Anticancer Res; 2011 Jun; 31(6):2045-51. PubMed ID: 21737621
[TBL] [Abstract][Full Text] [Related]
2. Effect of implantation site and growth of hepatocellular carcinoma on apparent diffusion coefficient of water and sodium MRI.
Babsky AM; Ju S; Bennett S; George B; McLennan G; Bansal N
NMR Biomed; 2012 Feb; 25(2):312-21. PubMed ID: 21823182
[TBL] [Abstract][Full Text] [Related]
3. The effect of benzamide riboside on the VX2 model of liver cancer in rabbits.
McLennan G; Cressman EN; Xu Y; Zhang D; Jagtap MR; Jayaram HN
J Vasc Interv Radiol; 2005 Nov; 16(11):1499-504. PubMed ID: 16319157
[TBL] [Abstract][Full Text] [Related]
4. Tumor response and apoptosis of N1-S1 rodent hepatomas in response to intra-arterial and intravenous benzamide riboside.
McLennan G; Bennett SL; Ju S; Babsky A; Bansal N; Shorten ML; Levitin S; Bonnac L; Panciewicz KW; Jayaram HN
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):645-52. PubMed ID: 21431971
[TBL] [Abstract][Full Text] [Related]
5. Variability of apoptosis and response in N1-S1 rodent hepatomas to benzamide riboside and correlation to early changes in water apparent diffusion coefficient and sodium MR imaging.
Faramarzalian A; McLennan G; Bennett SL; Babsky A; Bansal N; Lieber M; Bonnac L; Pankiewicz K; Jayaram HN
J Vasc Interv Radiol; 2013 Jun; 24(6):894-900. PubMed ID: 23566523
[TBL] [Abstract][Full Text] [Related]
6. Predicting and monitoring response to chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea in subcutaneously implanted 9L glioma using the apparent diffusion coefficient of water and 23Na MRI.
Babsky AM; Hekmatyar SK; Zhang H; Solomon JL; Bansal N
J Magn Reson Imaging; 2006 Jul; 24(1):132-9. PubMed ID: 16758478
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].
Fan WJ; Zhang L; Ouyang YS
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2474-7. PubMed ID: 19080627
[TBL] [Abstract][Full Text] [Related]
8. Early detection of therapeutic response to hepatic arterial infusion chemotherapy of liver metastases from colorectal cancer using diffusion-weighted MR imaging.
Marugami N; Tanaka T; Kitano S; Hirohashi S; Nishiofuku H; Takahashi A; Sakaguchi H; Matsuoka M; Otsuji T; Takahama J; Higashiura W; Kichikawa K
Cardiovasc Intervent Radiol; 2009 Jul; 32(4):638-46. PubMed ID: 19238482
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted magnetic resonance imaging of focal hepatic nodules in an experimental hepatocellular carcinoma rat model.
Xu H; Li X; Xie JX; Yang ZH; Wang B
Acad Radiol; 2007 Mar; 14(3):279-86. PubMed ID: 17307660
[TBL] [Abstract][Full Text] [Related]
10. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
Rhee TK; Naik NK; Deng J; Atassi B; Mulcahy MF; Kulik LM; Ryu RK; Miller FH; Larson AC; Salem R; Omary RA
J Vasc Interv Radiol; 2008 Aug; 19(8):1180-6. PubMed ID: 18656011
[TBL] [Abstract][Full Text] [Related]
11. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Sharma U; Danishad KK; Seenu V; Jagannathan NR
NMR Biomed; 2009 Jan; 22(1):104-13. PubMed ID: 18384182
[TBL] [Abstract][Full Text] [Related]
13. [Application of diffusion-weighted and perfusion magnetic resonance imaging in definition of the ischemic penumbra in hyperacute cerebral infarction].
Feng XY; Liang J; Yin XD; Han X; Dong Q; Lü CZ
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):952-7. PubMed ID: 12899795
[TBL] [Abstract][Full Text] [Related]
14. [Noninvasive monitoring of the hepatocellular carcinoma growth by the method of 1H and 23Na nuclear magnetic resonance].
Babs'kyĭ AM; Ju S; Topper S; Bennett S; Atthe B; McLennan G; Bansal N
Ukr Biokhim Zh (1999); 2008; 80(4):130-7. PubMed ID: 19140459
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted MRI of hepatic tumor in rats: comparison between in vivo and postmortem imaging acquisitions.
Sun X; Wang H; Chen F; De Keyzer F; Yu J; Jiang Y; Feng Y; Li J; Marchal G; Ni Y
J Magn Reson Imaging; 2009 Mar; 29(3):621-8. PubMed ID: 19243058
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance diffusion-weighted imaging in the diagnosis of diffuse liver diseases in rats.
Guan S; Zhou KR; Zhao WD; Peng WJ; Tang F; Mao J
Chin Med J (Engl); 2005 Apr; 118(8):639-44. PubMed ID: 15899118
[TBL] [Abstract][Full Text] [Related]
17. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
[TBL] [Abstract][Full Text] [Related]
18. [Pseudonormalization of diffusion weighted images: magnetic resonance imaging in an animal model (C6-glioma)].
Hartmann M; Junkers R; Herold-Mende C; Ahmadi R; Heiland S
Rofo; 2005 Jan; 177(1):114-8. PubMed ID: 15657829
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas.
Dudeck O; Zeile M; Pink D; Pech M; Tunn PU; Reichardt P; Ludwig WD; Hamm B
J Magn Reson Imaging; 2008 May; 27(5):1109-13. PubMed ID: 18425832
[TBL] [Abstract][Full Text] [Related]
20. Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma.
Kamel IR; Reyes DK; Liapi E; Bluemke DA; Geschwind JF
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):49-56. PubMed ID: 17296704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
